ADLIN Science has been selected by Challenges magazine as one of the 100 start-ups to invest in in 2024.
We also had the privilege of being named the most promising start-up in the "Digital Services" category. A wonderful recognition that reinforces our vision and the commitment of the whole team.
This distinction highlights our mission: to decompartmentalize healthcare data, and encourage its structuring and use within an ethical, secure and collaborative framework, in order to accelerate biomedical research and advance precision medicine.
